The Pharmaceutical Research and Manufacturers of America (PhRMA) recently named John Castellani as its new president and CEO. He takes over at a time when the pharmaceutical industry is suffering from a series of internal and external problems. Which issue most demands the new PhRMA executive’s attention?
What should PhRMA focus on?
Relations with the U.S. Congress
Public relations for the industry
All of the above